Related stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Related stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
TherapeuticsMD is a pharmaceutical royalty company that owns or has rights to trademarks, service marks, or trade names that were previously used in connection with the operation of its business, or are now licensed by another party, including TherapeuticsMD , vitaMedMD , BocaGreenMD , BIJUVA , and IMVEXXY , which are protected under applicable intellectual property laws and are the property of…
The business is unprofitable at the operating level (-145.27% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 71.6% YoY with margins expanding 201.8pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$3M
▲ +71.6% YoY
Net Income (TTM)
$179K
▲ +73.9% YoY
Op. Margin
-114.29%
▲ +201.8pp YoY
ROIC
-9.06%
▲ +3.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3M
▲ +109.7% YoY
Op. Cash Flow (TTM)
$3M
▲ +109.7% YoY
Net Debt
-$3M
Net Cash Position
Cash & Equiv.
$8M
5Y CAGR: -45.8%
Continue Research